Hypotensive effect of profilin on rabbit intraocular pressure

被引:13
|
作者
Morales, Miguel
Gomez-Cabrero, Azucena
Peral, Assumpta
Gasull, Xavier
Pintor, Jesus
机构
[1] Univ Barcelona, Sch Med, Inst Biomed Invest August Pi I Sunyer IDIBAPS, Dept Physiol 1 Lab Neurophysiol, E-08036 Barcelona, Spain
[2] Univ Complutense, Dept Opt 2, E-28037 Madrid, Spain
关键词
glaucoma; IOP; intraocular pressure; PTD4-profilin;
D O I
10.1016/j.ejphar.2007.04.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ocular hypertension is a negative process that occurs within the eye and is the main risk factor to develop glaucoma, a progressive loss of vision due to degeneration of retinal ganglion cells. The protein transduction technique allows a cargo to cross biological membranes. Using this technique we have previously shown that a membrane permeable version of profilin I (PTD4-profilin) increased aqueous humour outflow facility. Here we have investigated if a topical application of PTD4-profilin was able to modify intraocular pressure in rabbits. 10 mu M PTD4-profilin (10 mu L), reduced intraocular pressure by 20% compared to the control vehicle, this value being in the range of other commercial drugs, which produced intraocular pressure reductions between 18 and 35%. The mean-time effect for PTD4-profilin was 6.8 h and was also in the same range as commercial products that provided values between 4.3 and 5.5 h. According to the results presented here we propose PTD4-profilin as a new approach for the treatment of ocular hypertension and PTD4 as a new strategy to facilitate the penetration of molecules into the eye. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:145 / 148
页数:4
相关论文
共 50 条
  • [31] EFFECT OF D-ISOPROTERENOL ON INTRAOCULAR-PRESSURE OF RABBIT, MONKEY, AND MAN
    KASS, MA
    REID, TW
    NEUFELD, AH
    BAUSHER, LP
    SEARS, ML
    INVESTIGATIVE OPHTHALMOLOGY, 1976, 15 (02): : 113 - 118
  • [32] EFFECT OF SHORT-TERM INTRAOCULAR-PRESSURE ELEVATION ON THE RABBIT ELECTRORETINOGRAM
    FEGHALI, JG
    JIN, JC
    ODOM, JV
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (08) : 2184 - 2189
  • [33] Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
    Hayashi, Ken
    Yoshida, Motoaki
    Sato, Tatshuhiko
    Manabe, Shin-Ichi
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 205 : 91 - 98
  • [34] The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents
    Hoyng, PFJ
    Rulo, A
    Greve, E
    Watson, P
    Alm, A
    SURVEY OF OPHTHALMOLOGY, 1997, 41 : S93 - S98
  • [35] Melatonin analogues modulate rabbit intraocular pressure
    Pintor, JJ
    Pelaez, T
    Hoyle, CHV
    Peral, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1167 - U1167
  • [36] Intraocular pressure changes following topical ocular hypotensive medications washout
    Ho, Henrietta
    Daas, Arij
    Ho, Jason
    Alaghband, Pouya
    Galvis, Elizabeth Angela
    Ramirez, Alba de Antonio
    Grassi, Piergiacomo
    Lim, Rongxuan
    Lim, Kin Sheng
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (02) : 205 - 209
  • [37] Comment on: Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
    Daas, Arij
    Ho, Henrietta
    Lim, Kin Sheng
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 211 : 230 - 231
  • [38] COMBINED EFFECT OF FORSKOLIN AND ACETAZOLAMIDE ON INTRAOCULAR-PRESSURE AND AQUEOUS FLOW IN RABBIT EYES
    CAPRIOLI, J
    SEARS, M
    EXPERIMENTAL EYE RESEARCH, 1984, 39 (01) : 47 - 50
  • [39] EFFECT OF ARTIFICIALLY ELEVATED INTRAOCULAR PRESSURE ON ELECTRORETINOGRAM AND VISUALLY EVOKED CORTICAL POTENTIAL OF RABBIT
    UENOYAMA, K
    MCDONALD, JS
    DRANCE, SM
    CANADIAN JOURNAL OF OPHTHALMOLOGY, 1969, 4 (01): : 72 - &
  • [40] CANNABINOIDS IN GLAUCOMA .2. THE EFFECT OF DIFFERENT CANNABINOIDS ON INTRAOCULAR-PRESSURE OF THE RABBIT
    ELSOHLY, MA
    HARLAND, EC
    BENIGNI, DA
    WALLER, CW
    CURRENT EYE RESEARCH, 1984, 3 (06) : 841 - 850